nodes	percent_of_prediction	percent_of_DWPC	metapath
Glyburide—ABCB1—colon cancer	0.196	1	CbGaD
Glyburide—ABCC3—Fluorouracil—colon cancer	0.0583	0.093	CbGbCtD
Glyburide—ABCC3—Vincristine—colon cancer	0.0531	0.0847	CbGbCtD
Glyburide—ABCB11—Vincristine—colon cancer	0.0459	0.0732	CbGbCtD
Glyburide—SLC22A7—Fluorouracil—colon cancer	0.0456	0.0727	CbGbCtD
Glyburide—ABCC1—Irinotecan—colon cancer	0.0373	0.0595	CbGbCtD
Glyburide—ABCC1—Vincristine—colon cancer	0.0326	0.052	CbGbCtD
Glyburide—ABCC3—Methotrexate—colon cancer	0.0321	0.0513	CbGbCtD
Glyburide—ABCC2—Irinotecan—colon cancer	0.0276	0.044	CbGbCtD
Glyburide—SLC22A7—Methotrexate—colon cancer	0.0251	0.0401	CbGbCtD
Glyburide—ABCG2—Irinotecan—colon cancer	0.025	0.0398	CbGbCtD
Glyburide—ABCC2—Vincristine—colon cancer	0.0241	0.0385	CbGbCtD
Glyburide—ABCG2—Fluorouracil—colon cancer	0.024	0.0382	CbGbCtD
Glyburide—ABCG2—Vincristine—colon cancer	0.0218	0.0348	CbGbCtD
Glyburide—ABCC1—Methotrexate—colon cancer	0.0197	0.0315	CbGbCtD
Glyburide—SLCO1A2—Methotrexate—colon cancer	0.0176	0.0281	CbGbCtD
Glyburide—ALB—Irinotecan—colon cancer	0.0172	0.0274	CbGbCtD
Glyburide—ALB—Fluorouracil—colon cancer	0.0165	0.0263	CbGbCtD
Glyburide—CYP2C9—Capecitabine—colon cancer	0.015	0.0239	CbGbCtD
Glyburide—ABCC2—Methotrexate—colon cancer	0.0146	0.0233	CbGbCtD
Glyburide—ABCG2—Methotrexate—colon cancer	0.0132	0.0211	CbGbCtD
Glyburide—SLC22A6—Methotrexate—colon cancer	0.0107	0.0171	CbGbCtD
Glyburide—ALB—Methotrexate—colon cancer	0.00911	0.0145	CbGbCtD
Glyburide—ABCB1—Irinotecan—colon cancer	0.009	0.0144	CbGbCtD
Glyburide—CYP2C9—Fluorouracil—colon cancer	0.0089	0.0142	CbGbCtD
Glyburide—ABCB11—bile—colon cancer	0.00828	0.116	CbGeAlD
Glyburide—ABCB1—Vincristine—colon cancer	0.00787	0.0125	CbGbCtD
Glyburide—CYP3A4—Irinotecan—colon cancer	0.00539	0.0086	CbGbCtD
Glyburide—ABCB1—Methotrexate—colon cancer	0.00476	0.0076	CbGbCtD
Glyburide—CYP3A4—Vincristine—colon cancer	0.00471	0.00752	CbGbCtD
Glyburide—ABCC2—bile—colon cancer	0.00421	0.0591	CbGeAlD
Glyburide—ABCA1—blood vessel—colon cancer	0.00315	0.0443	CbGeAlD
Glyburide—CFTR—gall bladder—colon cancer	0.0028	0.0393	CbGeAlD
Glyburide—KCNJ5—lymphoid tissue—colon cancer	0.0023	0.0323	CbGeAlD
Glyburide—ABCC9—smooth muscle tissue—colon cancer	0.00218	0.0306	CbGeAlD
Glyburide—Myelosuppression—Vincristine—colon cancer	0.00165	0.0242	CcSEcCtD
Glyburide—Cerebrovascular disorder—Fluorouracil—colon cancer	0.00162	0.0237	CcSEcCtD
Glyburide—Myelosuppression—Fluorouracil—colon cancer	0.00154	0.0226	CcSEcCtD
Glyburide—CPT1A—renal system—colon cancer	0.00153	0.0215	CbGeAlD
Glyburide—Gliclazide—VEGFA—colon cancer	0.00151	0.395	CrCbGaD
Glyburide—KCNJ1—renal system—colon cancer	0.0015	0.021	CbGeAlD
Glyburide—ABCC3—gall bladder—colon cancer	0.00146	0.0205	CbGeAlD
Glyburide—CFTR—epithelium—colon cancer	0.00145	0.0204	CbGeAlD
Glyburide—ABCA1—renal system—colon cancer	0.00142	0.02	CbGeAlD
Glyburide—Blindness—Vincristine—colon cancer	0.0014	0.0205	CcSEcCtD
Glyburide—CFTR—renal system—colon cancer	0.00134	0.0189	CbGeAlD
Glyburide—Inappropriate antidiuretic hormone secretion—Vincristine—colon cancer	0.00133	0.0196	CcSEcCtD
Glyburide—ABCC9—liver—colon cancer	0.00128	0.018	CbGeAlD
Glyburide—Hepatitis cholestatic—Capecitabine—colon cancer	0.00125	0.0184	CcSEcCtD
Glyburide—CPT1A—digestive system—colon cancer	0.00125	0.0176	CbGeAlD
Glyburide—ALB—gall bladder—colon cancer	0.00125	0.0175	CbGeAlD
Glyburide—Allergic cutaneous angiitis—Methotrexate—colon cancer	0.00118	0.0173	CcSEcCtD
Glyburide—ABCA1—lymphoid tissue—colon cancer	0.00118	0.0166	CbGeAlD
Glyburide—ABCA1—digestive system—colon cancer	0.00117	0.0164	CbGeAlD
Glyburide—Glipizide—PPARG—colon cancer	0.00116	0.304	CrCbGaD
Glyburide—Reaction gastrointestinal—Methotrexate—colon cancer	0.00113	0.0165	CcSEcCtD
Glyburide—Encephalopathy—Fluorouracil—colon cancer	0.00113	0.0165	CcSEcCtD
Glyburide—CPT1A—vagina—colon cancer	0.00111	0.0155	CbGeAlD
Glyburide—CFTR—digestive system—colon cancer	0.0011	0.0155	CbGeAlD
Glyburide—Heartburn—Fluorouracil—colon cancer	0.00105	0.0154	CcSEcCtD
Glyburide—ABCA1—vagina—colon cancer	0.00103	0.0145	CbGeAlD
Glyburide—SLC22A7—renal system—colon cancer	0.000994	0.014	CbGeAlD
Glyburide—ABCC9—lymph node—colon cancer	0.000983	0.0138	CbGeAlD
Glyburide—CPT1A—liver—colon cancer	0.000933	0.0131	CbGeAlD
Glyburide—ABCB11—digestive system—colon cancer	0.000904	0.0127	CbGeAlD
Glyburide—ABCA1—liver—colon cancer	0.00087	0.0122	CbGeAlD
Glyburide—ABCC8—smooth muscle tissue—colon cancer	0.000868	0.0122	CbGeAlD
Glyburide—SLC15A1—epithelium—colon cancer	0.000861	0.0121	CbGeAlD
Glyburide—Bezafibrate—PPARG—colon cancer	0.000849	0.222	CrCbGaD
Glyburide—ABCC8—renal system—colon cancer	0.000836	0.0117	CbGeAlD
Glyburide—Hyperbilirubinaemia—Irinotecan—colon cancer	0.00083	0.0122	CcSEcCtD
Glyburide—CFTR—liver—colon cancer	0.000821	0.0115	CbGeAlD
Glyburide—SLC22A7—digestive system—colon cancer	0.000816	0.0115	CbGeAlD
Glyburide—SLC15A1—renal system—colon cancer	0.000799	0.0112	CbGeAlD
Glyburide—Nephropathy—Methotrexate—colon cancer	0.00079	0.0116	CcSEcCtD
Glyburide—Encephalopathy—Capecitabine—colon cancer	0.000787	0.0115	CcSEcCtD
Glyburide—Leukocytoclastic vasculitis—Methotrexate—colon cancer	0.000767	0.0112	CcSEcCtD
Glyburide—KCNJ11—lymphoid tissue—colon cancer	0.000753	0.0106	CbGeAlD
Glyburide—CPT1A—lymph node—colon cancer	0.000716	0.0101	CbGeAlD
Glyburide—ABCC3—renal system—colon cancer	0.000702	0.00986	CbGeAlD
Glyburide—ABCB11—liver—colon cancer	0.000674	0.00946	CbGeAlD
Glyburide—ABCA1—lymph node—colon cancer	0.000667	0.00936	CbGeAlD
Glyburide—SLC15A1—digestive system—colon cancer	0.000655	0.0092	CbGeAlD
Glyburide—SLCO2B1—renal system—colon cancer	0.000654	0.00919	CbGeAlD
Glyburide—Coagulopathy—Capecitabine—colon cancer	0.000649	0.00952	CcSEcCtD
Glyburide—Deafness—Vincristine—colon cancer	0.000629	0.00922	CcSEcCtD
Glyburide—Hepatic failure—Vincristine—colon cancer	0.000626	0.00918	CcSEcCtD
Glyburide—Eruption—Methotrexate—colon cancer	0.000612	0.00897	CcSEcCtD
Glyburide—SLC22A7—liver—colon cancer	0.000608	0.00853	CbGeAlD
Glyburide—SLCO1A2—renal system—colon cancer	0.000602	0.00845	CbGeAlD
Glyburide—Renal failure acute—Irinotecan—colon cancer	0.000594	0.0087	CcSEcCtD
Glyburide—Encephalopathy—Methotrexate—colon cancer	0.000586	0.00859	CcSEcCtD
Glyburide—SLC15A1—vagina—colon cancer	0.000579	0.00813	CbGeAlD
Glyburide—Visual disturbance—Irinotecan—colon cancer	0.000578	0.00848	CcSEcCtD
Glyburide—Renal impairment—Irinotecan—colon cancer	0.000576	0.00844	CcSEcCtD
Glyburide—ABCC3—digestive system—colon cancer	0.000576	0.00808	CbGeAlD
Glyburide—Hyponatraemia—Vincristine—colon cancer	0.000565	0.00829	CcSEcCtD
Glyburide—ABCC2—renal system—colon cancer	0.000561	0.00788	CbGeAlD
Glyburide—Hyperbilirubinaemia—Capecitabine—colon cancer	0.000556	0.00815	CcSEcCtD
Glyburide—Hyponatraemia—Irinotecan—colon cancer	0.00055	0.00807	CcSEcCtD
Glyburide—Dermatitis bullous—Fluorouracil—colon cancer	0.000549	0.00805	CcSEcCtD
Glyburide—SLCO2B1—digestive system—colon cancer	0.000536	0.00754	CbGeAlD
Glyburide—SLC15A2—renal system—colon cancer	0.000499	0.00702	CbGeAlD
Glyburide—SLCO1A2—digestive system—colon cancer	0.000494	0.00693	CbGeAlD
Glyburide—SLC15A1—liver—colon cancer	0.000488	0.00686	CbGeAlD
Glyburide—Abdominal distension—Irinotecan—colon cancer	0.000477	0.00699	CcSEcCtD
Glyburide—Pancreatitis—Irinotecan—colon cancer	0.000464	0.00681	CcSEcCtD
Glyburide—Pancytopenia—Vincristine—colon cancer	0.000462	0.00677	CcSEcCtD
Glyburide—Sweating increased—Irinotecan—colon cancer	0.000461	0.00677	CcSEcCtD
Glyburide—ABCC2—digestive system—colon cancer	0.00046	0.00646	CbGeAlD
Glyburide—Eosinophilia—Fluorouracil—colon cancer	0.000449	0.00659	CcSEcCtD
Glyburide—ABCB1—blood vessel—colon cancer	0.000447	0.00627	CbGeAlD
Glyburide—Photosensitivity reaction—Vincristine—colon cancer	0.000444	0.00651	CcSEcCtD
Glyburide—Pancytopenia—Fluorouracil—colon cancer	0.000431	0.00632	CcSEcCtD
Glyburide—ABCC3—liver—colon cancer	0.000429	0.00602	CbGeAlD
Glyburide—KCNJ11—lymph node—colon cancer	0.000425	0.00597	CbGeAlD
Glyburide—Hepatic function abnormal—Capecitabine—colon cancer	0.00042	0.00615	CcSEcCtD
Glyburide—Photosensitivity reaction—Fluorouracil—colon cancer	0.000414	0.00607	CcSEcCtD
Glyburide—Hyperbilirubinaemia—Methotrexate—colon cancer	0.000414	0.00607	CcSEcCtD
Glyburide—Jaundice—Irinotecan—colon cancer	0.000412	0.00604	CcSEcCtD
Glyburide—Deafness—Capecitabine—colon cancer	0.00041	0.00601	CcSEcCtD
Glyburide—Vascular purpura—Capecitabine—colon cancer	0.00041	0.00601	CcSEcCtD
Glyburide—Hepatic failure—Capecitabine—colon cancer	0.000408	0.00599	CcSEcCtD
Glyburide—Haemolytic anaemia—Capecitabine—colon cancer	0.000406	0.00596	CcSEcCtD
Glyburide—SLCO2B1—liver—colon cancer	0.0004	0.00561	CbGeAlD
Glyburide—Renal failure acute—Capecitabine—colon cancer	0.000397	0.00583	CcSEcCtD
Glyburide—CYP2C19—digestive system—colon cancer	0.000395	0.00555	CbGeAlD
Glyburide—Renal impairment—Capecitabine—colon cancer	0.000385	0.00565	CcSEcCtD
Glyburide—Vasculitis—Methotrexate—colon cancer	0.000385	0.00565	CcSEcCtD
Glyburide—Dermatitis bullous—Capecitabine—colon cancer	0.000384	0.00563	CcSEcCtD
Glyburide—Purpura—Capecitabine—colon cancer	0.000381	0.00558	CcSEcCtD
Glyburide—Agranulocytosis—Fluorouracil—colon cancer	0.000378	0.00554	CcSEcCtD
Glyburide—Arthritis—Capecitabine—colon cancer	0.000377	0.00553	CcSEcCtD
Glyburide—Hyponatraemia—Capecitabine—colon cancer	0.000368	0.0054	CcSEcCtD
Glyburide—SLCO1A2—liver—colon cancer	0.000368	0.00517	CbGeAlD
Glyburide—Diplopia—Capecitabine—colon cancer	0.000367	0.00538	CcSEcCtD
Glyburide—ALB—liver—colon cancer	0.000366	0.00514	CbGeAlD
Glyburide—Visual impairment—Irinotecan—colon cancer	0.000365	0.00536	CcSEcCtD
Glyburide—SLC15A2—vagina—colon cancer	0.000362	0.00508	CbGeAlD
Glyburide—ABCC1—vagina—colon cancer	0.000358	0.00502	CbGeAlD
Glyburide—Aplastic anaemia—Methotrexate—colon cancer	0.000353	0.00518	CcSEcCtD
Glyburide—CYP2C19—vagina—colon cancer	0.000349	0.0049	CbGeAlD
Glyburide—Alopecia—Vincristine—colon cancer	0.000344	0.00504	CcSEcCtD
Glyburide—ABCC2—liver—colon cancer	0.000343	0.00481	CbGeAlD
Glyburide—Alopecia—Irinotecan—colon cancer	0.000335	0.00491	CcSEcCtD
Glyburide—ABCC3—lymph node—colon cancer	0.000329	0.00462	CbGeAlD
Glyburide—Alopecia—Fluorouracil—colon cancer	0.000321	0.00471	CcSEcCtD
Glyburide—Abdominal distension—Capecitabine—colon cancer	0.000319	0.00468	CcSEcCtD
Glyburide—Erythema—Fluorouracil—colon cancer	0.000316	0.00464	CcSEcCtD
Glyburide—Anaemia—Vincristine—colon cancer	0.000313	0.00459	CcSEcCtD
Glyburide—ABCG2—bone marrow—colon cancer	0.000309	0.00434	CbGeAlD
Glyburide—Sweating increased—Capecitabine—colon cancer	0.000309	0.00453	CcSEcCtD
Glyburide—SLCO2B1—lymph node—colon cancer	0.000306	0.0043	CbGeAlD
Glyburide—CYP2C9—digestive system—colon cancer	0.000306	0.0043	CbGeAlD
Glyburide—Anaemia—Irinotecan—colon cancer	0.000305	0.00447	CcSEcCtD
Glyburide—Hepatic failure—Methotrexate—colon cancer	0.000304	0.00446	CcSEcCtD
Glyburide—Leukopenia—Vincristine—colon cancer	0.000303	0.00445	CcSEcCtD
Glyburide—Chlorpropamide—ABCB1—colon cancer	0.000302	0.0789	CrCbGaD
Glyburide—ABCC1—liver—colon cancer	0.000302	0.00424	CbGeAlD
Glyburide—Pancytopenia—Capecitabine—colon cancer	0.000301	0.00441	CcSEcCtD
Glyburide—Vision blurred—Fluorouracil—colon cancer	0.000298	0.00437	CcSEcCtD
Glyburide—ABCG2—vagina—colon cancer	0.000296	0.00416	CbGeAlD
Glyburide—Renal failure acute—Methotrexate—colon cancer	0.000296	0.00434	CcSEcCtD
Glyburide—Leukopenia—Irinotecan—colon cancer	0.000295	0.00433	CcSEcCtD
Glyburide—CYP2C19—liver—colon cancer	0.000294	0.00414	CbGeAlD
Glyburide—Convulsion—Vincristine—colon cancer	0.000294	0.00431	CcSEcCtD
Glyburide—Anaemia—Fluorouracil—colon cancer	0.000292	0.00428	CcSEcCtD
Glyburide—Photosensitivity reaction—Capecitabine—colon cancer	0.000289	0.00424	CcSEcCtD
Glyburide—Myalgia—Vincristine—colon cancer	0.000289	0.00423	CcSEcCtD
Glyburide—Visual disturbance—Methotrexate—colon cancer	0.000288	0.00423	CcSEcCtD
Glyburide—CYP3A4—renal system—colon cancer	0.000285	0.004	CbGeAlD
Glyburide—Leukopenia—Fluorouracil—colon cancer	0.000283	0.00415	CcSEcCtD
Glyburide—ALB—lymph node—colon cancer	0.00028	0.00394	CbGeAlD
Glyburide—Oedema—Vincristine—colon cancer	0.000277	0.00406	CcSEcCtD
Glyburide—Jaundice—Capecitabine—colon cancer	0.000276	0.00404	CcSEcCtD
Glyburide—Convulsion—Fluorouracil—colon cancer	0.000274	0.00402	CcSEcCtD
Glyburide—Confusional state—Irinotecan—colon cancer	0.000272	0.00398	CcSEcCtD
Glyburide—Nervous system disorder—Vincristine—colon cancer	0.000271	0.00398	CcSEcCtD
Glyburide—Thrombocytopenia—Vincristine—colon cancer	0.000271	0.00397	CcSEcCtD
Glyburide—Oedema—Irinotecan—colon cancer	0.000269	0.00395	CcSEcCtD
Glyburide—Myalgia—Fluorouracil—colon cancer	0.000269	0.00395	CcSEcCtD
Glyburide—Hyperhidrosis—Vincristine—colon cancer	0.000267	0.00392	CcSEcCtD
Glyburide—ABCB1—embryo—colon cancer	0.000266	0.00374	CbGeAlD
Glyburide—Shock—Irinotecan—colon cancer	0.000265	0.00389	CcSEcCtD
Glyburide—Nervous system disorder—Irinotecan—colon cancer	0.000264	0.00387	CcSEcCtD
Glyburide—Agranulocytosis—Capecitabine—colon cancer	0.000264	0.00387	CcSEcCtD
Glyburide—Thrombocytopenia—Irinotecan—colon cancer	0.000264	0.00387	CcSEcCtD
Glyburide—Anorexia—Vincristine—colon cancer	0.000264	0.00387	CcSEcCtD
Glyburide—ABCC2—lymph node—colon cancer	0.000263	0.00369	CbGeAlD
Glyburide—Hyperhidrosis—Irinotecan—colon cancer	0.00026	0.00382	CcSEcCtD
Glyburide—Confusional state—Fluorouracil—colon cancer	0.00026	0.00381	CcSEcCtD
Glyburide—Hypotension—Vincristine—colon cancer	0.000258	0.00379	CcSEcCtD
Glyburide—Oedema—Fluorouracil—colon cancer	0.000258	0.00378	CcSEcCtD
Glyburide—Anorexia—Irinotecan—colon cancer	0.000257	0.00377	CcSEcCtD
Glyburide—Hepatitis—Capecitabine—colon cancer	0.000254	0.00372	CcSEcCtD
Glyburide—Nervous system disorder—Fluorouracil—colon cancer	0.000253	0.00371	CcSEcCtD
Glyburide—Thrombocytopenia—Fluorouracil—colon cancer	0.000253	0.0037	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Vincristine—colon cancer	0.000252	0.0037	CcSEcCtD
Glyburide—Hypotension—Irinotecan—colon cancer	0.000252	0.00369	CcSEcCtD
Glyburide—ABCG2—liver—colon cancer	0.00025	0.00351	CbGeAlD
Glyburide—Paraesthesia—Vincristine—colon cancer	0.000248	0.00364	CcSEcCtD
Glyburide—Anorexia—Fluorouracil—colon cancer	0.000246	0.00361	CcSEcCtD
Glyburide—Visual impairment—Capecitabine—colon cancer	0.000245	0.00359	CcSEcCtD
Glyburide—Paraesthesia—Irinotecan—colon cancer	0.000242	0.00355	CcSEcCtD
Glyburide—Hypotension—Fluorouracil—colon cancer	0.000241	0.00354	CcSEcCtD
Glyburide—Decreased appetite—Vincristine—colon cancer	0.00024	0.00353	CcSEcCtD
Glyburide—Dyspnoea—Irinotecan—colon cancer	0.00024	0.00352	CcSEcCtD
Glyburide—Gastrointestinal disorder—Vincristine—colon cancer	0.000239	0.0035	CcSEcCtD
Glyburide—Eye disorder—Capecitabine—colon cancer	0.000237	0.00348	CcSEcCtD
Glyburide—Dyspepsia—Irinotecan—colon cancer	0.000237	0.00348	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000235	0.00345	CcSEcCtD
Glyburide—Decreased appetite—Irinotecan—colon cancer	0.000234	0.00343	CcSEcCtD
Glyburide—SLC15A2—lymph node—colon cancer	0.000234	0.00329	CbGeAlD
Glyburide—Eosinophilia—Methotrexate—colon cancer	0.000234	0.00343	CcSEcCtD
Glyburide—CYP3A4—digestive system—colon cancer	0.000234	0.00328	CbGeAlD
Glyburide—Gastrointestinal disorder—Irinotecan—colon cancer	0.000233	0.00341	CcSEcCtD
Glyburide—Paraesthesia—Fluorouracil—colon cancer	0.000232	0.0034	CcSEcCtD
Glyburide—Pancreatitis—Methotrexate—colon cancer	0.000231	0.00339	CcSEcCtD
Glyburide—ABCC1—lymph node—colon cancer	0.000231	0.00325	CbGeAlD
Glyburide—Dyspnoea—Fluorouracil—colon cancer	0.00023	0.00337	CcSEcCtD
Glyburide—CYP2C9—liver—colon cancer	0.000228	0.00321	CbGeAlD
Glyburide—Dyspepsia—Fluorouracil—colon cancer	0.000227	0.00333	CcSEcCtD
Glyburide—Gastrointestinal pain—Vincristine—colon cancer	0.000226	0.00332	CcSEcCtD
Glyburide—Decreased appetite—Fluorouracil—colon cancer	0.000224	0.00329	CcSEcCtD
Glyburide—Alopecia—Capecitabine—colon cancer	0.000224	0.00329	CcSEcCtD
Glyburide—Pancytopenia—Methotrexate—colon cancer	0.000224	0.00329	CcSEcCtD
Glyburide—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000223	0.00327	CcSEcCtD
Glyburide—Feeling abnormal—Irinotecan—colon cancer	0.000222	0.00326	CcSEcCtD
Glyburide—Erythema—Capecitabine—colon cancer	0.000221	0.00324	CcSEcCtD
Glyburide—Malnutrition—Capecitabine—colon cancer	0.000221	0.00324	CcSEcCtD
Glyburide—Gastrointestinal pain—Irinotecan—colon cancer	0.00022	0.00323	CcSEcCtD
Glyburide—Abdominal pain—Vincristine—colon cancer	0.000219	0.00321	CcSEcCtD
Glyburide—ABCB1—epithelium—colon cancer	0.000217	0.00305	CbGeAlD
Glyburide—Photosensitivity reaction—Methotrexate—colon cancer	0.000215	0.00316	CcSEcCtD
Glyburide—Abdominal pain—Irinotecan—colon cancer	0.000213	0.00312	CcSEcCtD
Glyburide—Feeling abnormal—Fluorouracil—colon cancer	0.000213	0.00312	CcSEcCtD
Glyburide—Vision blurred—Capecitabine—colon cancer	0.000208	0.00305	CcSEcCtD
Glyburide—Tremor—Capecitabine—colon cancer	0.000207	0.00303	CcSEcCtD
Glyburide—Urticaria—Fluorouracil—colon cancer	0.000205	0.00301	CcSEcCtD
Glyburide—Anaemia—Capecitabine—colon cancer	0.000204	0.00299	CcSEcCtD
Glyburide—Hypersensitivity—Vincristine—colon cancer	0.000204	0.00299	CcSEcCtD
Glyburide—ABCB1—renal system—colon cancer	0.000202	0.00283	CbGeAlD
Glyburide—Hypersensitivity—Irinotecan—colon cancer	0.000198	0.00291	CcSEcCtD
Glyburide—Asthenia—Vincristine—colon cancer	0.000198	0.00291	CcSEcCtD
Glyburide—Leukopenia—Capecitabine—colon cancer	0.000198	0.0029	CcSEcCtD
Glyburide—Agranulocytosis—Methotrexate—colon cancer	0.000196	0.00288	CcSEcCtD
Glyburide—Asthenia—Irinotecan—colon cancer	0.000193	0.00283	CcSEcCtD
Glyburide—ABCG2—lymph node—colon cancer	0.000192	0.00269	CbGeAlD
Glyburide—Hypersensitivity—Fluorouracil—colon cancer	0.00019	0.00279	CcSEcCtD
Glyburide—Diarrhoea—Vincristine—colon cancer	0.000189	0.00278	CcSEcCtD
Glyburide—Hepatitis—Methotrexate—colon cancer	0.000189	0.00277	CcSEcCtD
Glyburide—Arthralgia—Capecitabine—colon cancer	0.000188	0.00276	CcSEcCtD
Glyburide—Myalgia—Capecitabine—colon cancer	0.000188	0.00276	CcSEcCtD
Glyburide—Diarrhoea—Irinotecan—colon cancer	0.000184	0.0027	CcSEcCtD
Glyburide—Pruritus—Fluorouracil—colon cancer	0.000183	0.00268	CcSEcCtD
Glyburide—Visual impairment—Methotrexate—colon cancer	0.000182	0.00267	CcSEcCtD
Glyburide—Confusional state—Capecitabine—colon cancer	0.000182	0.00267	CcSEcCtD
Glyburide—Oedema—Capecitabine—colon cancer	0.00018	0.00264	CcSEcCtD
Glyburide—Shock—Capecitabine—colon cancer	0.000177	0.0026	CcSEcCtD
Glyburide—Nervous system disorder—Capecitabine—colon cancer	0.000177	0.00259	CcSEcCtD
Glyburide—Eye disorder—Methotrexate—colon cancer	0.000177	0.00259	CcSEcCtD
Glyburide—Diarrhoea—Fluorouracil—colon cancer	0.000177	0.00259	CcSEcCtD
Glyburide—Thrombocytopenia—Capecitabine—colon cancer	0.000177	0.00259	CcSEcCtD
Glyburide—Vomiting—Vincristine—colon cancer	0.000176	0.00258	CcSEcCtD
Glyburide—Rash—Vincristine—colon cancer	0.000174	0.00256	CcSEcCtD
Glyburide—Hyperhidrosis—Capecitabine—colon cancer	0.000174	0.00256	CcSEcCtD
Glyburide—Dermatitis—Vincristine—colon cancer	0.000174	0.00255	CcSEcCtD
Glyburide—CYP3A4—liver—colon cancer	0.000174	0.00244	CbGeAlD
Glyburide—Headache—Vincristine—colon cancer	0.000173	0.00254	CcSEcCtD
Glyburide—Anorexia—Capecitabine—colon cancer	0.000172	0.00252	CcSEcCtD
Glyburide—Vomiting—Irinotecan—colon cancer	0.000171	0.00251	CcSEcCtD
Glyburide—Rash—Irinotecan—colon cancer	0.00017	0.00249	CcSEcCtD
Glyburide—Dermatitis—Irinotecan—colon cancer	0.00017	0.00249	CcSEcCtD
Glyburide—Headache—Irinotecan—colon cancer	0.000169	0.00247	CcSEcCtD
Glyburide—Hypotension—Capecitabine—colon cancer	0.000168	0.00247	CcSEcCtD
Glyburide—ABCB1—lymphoid tissue—colon cancer	0.000167	0.00235	CbGeAlD
Glyburide—Alopecia—Methotrexate—colon cancer	0.000167	0.00245	CcSEcCtD
Glyburide—ABCB1—digestive system—colon cancer	0.000165	0.00232	CbGeAlD
Glyburide—Malnutrition—Methotrexate—colon cancer	0.000164	0.00241	CcSEcCtD
Glyburide—Erythema—Methotrexate—colon cancer	0.000164	0.00241	CcSEcCtD
Glyburide—Nausea—Vincristine—colon cancer	0.000164	0.00241	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000164	0.00241	CcSEcCtD
Glyburide—Vomiting—Fluorouracil—colon cancer	0.000164	0.00241	CcSEcCtD
Glyburide—Rash—Fluorouracil—colon cancer	0.000163	0.00239	CcSEcCtD
Glyburide—Dermatitis—Fluorouracil—colon cancer	0.000163	0.00238	CcSEcCtD
Glyburide—Paraesthesia—Capecitabine—colon cancer	0.000162	0.00237	CcSEcCtD
Glyburide—Headache—Fluorouracil—colon cancer	0.000162	0.00237	CcSEcCtD
Glyburide—Dyspnoea—Capecitabine—colon cancer	0.000161	0.00236	CcSEcCtD
Glyburide—Nausea—Irinotecan—colon cancer	0.00016	0.00235	CcSEcCtD
Glyburide—Dyspepsia—Capecitabine—colon cancer	0.000159	0.00233	CcSEcCtD
Glyburide—Decreased appetite—Capecitabine—colon cancer	0.000157	0.0023	CcSEcCtD
Glyburide—Gastrointestinal disorder—Capecitabine—colon cancer	0.000156	0.00228	CcSEcCtD
Glyburide—Vision blurred—Methotrexate—colon cancer	0.000155	0.00227	CcSEcCtD
Glyburide—Nausea—Fluorouracil—colon cancer	0.000153	0.00225	CcSEcCtD
Glyburide—ABCB1—bone marrow—colon cancer	0.000152	0.00214	CbGeAlD
Glyburide—Anaemia—Methotrexate—colon cancer	0.000152	0.00223	CcSEcCtD
Glyburide—Feeling abnormal—Capecitabine—colon cancer	0.000149	0.00218	CcSEcCtD
Glyburide—Gastrointestinal pain—Capecitabine—colon cancer	0.000147	0.00216	CcSEcCtD
Glyburide—Leukopenia—Methotrexate—colon cancer	0.000147	0.00216	CcSEcCtD
Glyburide—ABCB1—vagina—colon cancer	0.000146	0.00205	CbGeAlD
Glyburide—Urticaria—Capecitabine—colon cancer	0.000143	0.0021	CcSEcCtD
Glyburide—Abdominal pain—Capecitabine—colon cancer	0.000143	0.00209	CcSEcCtD
Glyburide—Convulsion—Methotrexate—colon cancer	0.000143	0.00209	CcSEcCtD
Glyburide—Arthralgia—Methotrexate—colon cancer	0.00014	0.00205	CcSEcCtD
Glyburide—Myalgia—Methotrexate—colon cancer	0.00014	0.00205	CcSEcCtD
Glyburide—Confusional state—Methotrexate—colon cancer	0.000135	0.00198	CcSEcCtD
Glyburide—Hypersensitivity—Capecitabine—colon cancer	0.000133	0.00195	CcSEcCtD
Glyburide—Nervous system disorder—Methotrexate—colon cancer	0.000132	0.00193	CcSEcCtD
Glyburide—Thrombocytopenia—Methotrexate—colon cancer	0.000131	0.00193	CcSEcCtD
Glyburide—Hyperhidrosis—Methotrexate—colon cancer	0.00013	0.0019	CcSEcCtD
Glyburide—Asthenia—Capecitabine—colon cancer	0.000129	0.0019	CcSEcCtD
Glyburide—Anorexia—Methotrexate—colon cancer	0.000128	0.00188	CcSEcCtD
Glyburide—Pruritus—Capecitabine—colon cancer	0.000128	0.00187	CcSEcCtD
Glyburide—Hypotension—Methotrexate—colon cancer	0.000125	0.00184	CcSEcCtD
Glyburide—Diarrhoea—Capecitabine—colon cancer	0.000123	0.00181	CcSEcCtD
Glyburide—ABCB1—liver—colon cancer	0.000123	0.00173	CbGeAlD
Glyburide—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000122	0.00179	CcSEcCtD
Glyburide—Paraesthesia—Methotrexate—colon cancer	0.000121	0.00177	CcSEcCtD
Glyburide—Dyspnoea—Methotrexate—colon cancer	0.00012	0.00175	CcSEcCtD
Glyburide—Dyspepsia—Methotrexate—colon cancer	0.000118	0.00173	CcSEcCtD
Glyburide—Decreased appetite—Methotrexate—colon cancer	0.000117	0.00171	CcSEcCtD
Glyburide—Gastrointestinal disorder—Methotrexate—colon cancer	0.000116	0.0017	CcSEcCtD
Glyburide—Vomiting—Capecitabine—colon cancer	0.000115	0.00168	CcSEcCtD
Glyburide—Rash—Capecitabine—colon cancer	0.000114	0.00167	CcSEcCtD
Glyburide—Dermatitis—Capecitabine—colon cancer	0.000114	0.00167	CcSEcCtD
Glyburide—Headache—Capecitabine—colon cancer	0.000113	0.00166	CcSEcCtD
Glyburide—Feeling abnormal—Methotrexate—colon cancer	0.000111	0.00162	CcSEcCtD
Glyburide—Gastrointestinal pain—Methotrexate—colon cancer	0.00011	0.00161	CcSEcCtD
Glyburide—Nausea—Capecitabine—colon cancer	0.000107	0.00157	CcSEcCtD
Glyburide—Urticaria—Methotrexate—colon cancer	0.000107	0.00156	CcSEcCtD
Glyburide—Abdominal pain—Methotrexate—colon cancer	0.000106	0.00156	CcSEcCtD
Glyburide—Hypersensitivity—Methotrexate—colon cancer	9.89e-05	0.00145	CcSEcCtD
Glyburide—Asthenia—Methotrexate—colon cancer	9.63e-05	0.00141	CcSEcCtD
Glyburide—Pruritus—Methotrexate—colon cancer	9.5e-05	0.00139	CcSEcCtD
Glyburide—ABCB1—lymph node—colon cancer	9.45e-05	0.00133	CbGeAlD
Glyburide—Diarrhoea—Methotrexate—colon cancer	9.18e-05	0.00135	CcSEcCtD
Glyburide—Vomiting—Methotrexate—colon cancer	8.53e-05	0.00125	CcSEcCtD
Glyburide—Rash—Methotrexate—colon cancer	8.46e-05	0.00124	CcSEcCtD
Glyburide—Dermatitis—Methotrexate—colon cancer	8.46e-05	0.00124	CcSEcCtD
Glyburide—Headache—Methotrexate—colon cancer	8.41e-05	0.00123	CcSEcCtD
Glyburide—Nausea—Methotrexate—colon cancer	7.97e-05	0.00117	CcSEcCtD
Glyburide—ABCC9—Neuronal System—HRAS—colon cancer	5.56e-05	0.00165	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—ODC1—colon cancer	5.52e-05	0.00164	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—CHST5—colon cancer	5.52e-05	0.00164	CbGpPWpGaD
Glyburide—ABCG2—HIF-1-alpha transcription factor network—VEGFA—colon cancer	5.45e-05	0.00162	CbGpPWpGaD
Glyburide—CPT1A—Circadian rythm related genes—TP53—colon cancer	5.24e-05	0.00156	CbGpPWpGaD
Glyburide—ABCC8—Neuronal System—BRAF—colon cancer	5.18e-05	0.00154	CbGpPWpGaD
Glyburide—ABCC1—Disease—CHST5—colon cancer	5.16e-05	0.00153	CbGpPWpGaD
Glyburide—ABCC1—Disease—LGR5—colon cancer	5.16e-05	0.00153	CbGpPWpGaD
Glyburide—KCNJ11—Neuronal System—BRAF—colon cancer	5.02e-05	0.00149	CbGpPWpGaD
Glyburide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	4.98e-05	0.00148	CbGpPWpGaD
Glyburide—ABCA1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	4.87e-05	0.00145	CbGpPWpGaD
Glyburide—CPT1A—Metabolism of lipids and lipoproteins—PPARG—colon cancer	4.87e-05	0.00145	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—CHST5—colon cancer	4.8e-05	0.00143	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—ODC1—colon cancer	4.8e-05	0.00143	CbGpPWpGaD
Glyburide—CYP2C19—Arachidonic acid metabolism—PTGS2—colon cancer	4.79e-05	0.00142	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—colon cancer	4.68e-05	0.00139	CbGpPWpGaD
Glyburide—KCNJ1—Neuronal System—HRAS—colon cancer	4.66e-05	0.00138	CbGpPWpGaD
Glyburide—SLCO2B1—Transmembrane transport of small molecules—ABCB1—colon cancer	4.42e-05	0.00131	CbGpPWpGaD
Glyburide—CYP2C9—Arachidonic acid metabolism—PTGS2—colon cancer	4.37e-05	0.0013	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—ODC1—colon cancer	4.32e-05	0.00128	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—CHST5—colon cancer	4.32e-05	0.00128	CbGpPWpGaD
Glyburide—ABCC8—Transmembrane transport of small molecules—ABCB1—colon cancer	4.11e-05	0.00122	CbGpPWpGaD
Glyburide—ALB—Metabolism—CA7—colon cancer	3.87e-05	0.00115	CbGpPWpGaD
Glyburide—ABCC3—NRF2 pathway—TGFB1—colon cancer	3.85e-05	0.00114	CbGpPWpGaD
Glyburide—CPT1A—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	3.83e-05	0.00114	CbGpPWpGaD
Glyburide—ABCA1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	3.83e-05	0.00114	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—CHST5—colon cancer	3.8e-05	0.00113	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—ODC1—colon cancer	3.8e-05	0.00113	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—BUB1B—colon cancer	3.74e-05	0.00111	CbGpPWpGaD
Glyburide—ABCC1—Disease—AXIN2—colon cancer	3.71e-05	0.0011	CbGpPWpGaD
Glyburide—SLC15A2—Transmembrane transport of small molecules—ABCB1—colon cancer	3.7e-05	0.0011	CbGpPWpGaD
Glyburide—SLC22A7—Transmembrane transport of small molecules—ABCB1—colon cancer	3.63e-05	0.00108	CbGpPWpGaD
Glyburide—ABCG2—HIF-1-alpha transcription factor network—AKT1—colon cancer	3.48e-05	0.00103	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—CA7—colon cancer	3.48e-05	0.00103	CbGpPWpGaD
Glyburide—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—colon cancer	3.44e-05	0.00102	CbGpPWpGaD
Glyburide—SLC15A1—Transmembrane transport of small molecules—ABCB1—colon cancer	3.43e-05	0.00102	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—CA7—colon cancer	3.4e-05	0.00101	CbGpPWpGaD
Glyburide—ALB—Selenium Micronutrient Network—PTGS2—colon cancer	3.39e-05	0.00101	CbGpPWpGaD
Glyburide—ABCA1—Metabolism of lipids and lipoproteins—EP300—colon cancer	3.18e-05	0.000946	CbGpPWpGaD
Glyburide—CPT1A—Metabolism of lipids and lipoproteins—EP300—colon cancer	3.18e-05	0.000946	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—CA7—colon cancer	3.17e-05	0.000943	CbGpPWpGaD
Glyburide—ABCA1—Metabolism—ABCB1—colon cancer	3.11e-05	0.000926	CbGpPWpGaD
Glyburide—CPT1A—Metabolism—ABCB1—colon cancer	3.11e-05	0.000926	CbGpPWpGaD
Glyburide—ABCC3—Transmembrane transport of small molecules—ABCB1—colon cancer	3.11e-05	0.000925	CbGpPWpGaD
Glyburide—ABCB1—HIF-1-alpha transcription factor network—EP300—colon cancer	3.11e-05	0.000925	CbGpPWpGaD
Glyburide—CPT1A—Metabolism—TYMS—colon cancer	3.06e-05	0.000909	CbGpPWpGaD
Glyburide—ABCA1—Metabolism—TYMS—colon cancer	3.06e-05	0.000909	CbGpPWpGaD
Glyburide—ABCC2—NRF2 pathway—TGFB1—colon cancer	3.05e-05	0.000906	CbGpPWpGaD
Glyburide—ABCB1—Allograft Rejection—CASP3—colon cancer	3.01e-05	0.000894	CbGpPWpGaD
Glyburide—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—colon cancer	2.97e-05	0.000883	CbGpPWpGaD
Glyburide—ABCB1—HIF-1-alpha transcription factor network—VEGFA—colon cancer	2.95e-05	0.000876	CbGpPWpGaD
Glyburide—ALB—Platelet degranulation—VEGFA—colon cancer	2.89e-05	0.000857	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—colon cancer	2.87e-05	0.000853	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	2.77e-05	0.000822	CbGpPWpGaD
Glyburide—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—colon cancer	2.75e-05	0.000817	CbGpPWpGaD
Glyburide—SLCO1A2—Transmembrane transport of small molecules—ABCB1—colon cancer	2.71e-05	0.000806	CbGpPWpGaD
Glyburide—ALB—Platelet degranulation—TGFB1—colon cancer	2.65e-05	0.000787	CbGpPWpGaD
Glyburide—ABCB1—Allograft Rejection—VEGFA—colon cancer	2.55e-05	0.000759	CbGpPWpGaD
Glyburide—SLC22A6—Transmembrane transport of small molecules—ABCB1—colon cancer	2.55e-05	0.000757	CbGpPWpGaD
Glyburide—ALB—Folate Metabolism—TP53—colon cancer	2.54e-05	0.000756	CbGpPWpGaD
Glyburide—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—colon cancer	2.52e-05	0.00075	CbGpPWpGaD
Glyburide—ABCC2—Transmembrane transport of small molecules—ABCB1—colon cancer	2.47e-05	0.000734	CbGpPWpGaD
Glyburide—ABCC1—Transmembrane transport of small molecules—ABCB1—colon cancer	2.44e-05	0.000725	CbGpPWpGaD
Glyburide—ABCC8—Neuronal System—HRAS—colon cancer	2.38e-05	0.000707	CbGpPWpGaD
Glyburide—ABCB11—Metabolism of lipids and lipoproteins—PPARG—colon cancer	2.38e-05	0.000706	CbGpPWpGaD
Glyburide—ABCA1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	2.35e-05	0.0007	CbGpPWpGaD
Glyburide—CPT1A—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	2.35e-05	0.0007	CbGpPWpGaD
Glyburide—ALB—Metabolism—CHST5—colon cancer	2.35e-05	0.000698	CbGpPWpGaD
Glyburide—ALB—Metabolism—ODC1—colon cancer	2.35e-05	0.000698	CbGpPWpGaD
Glyburide—ABCB1—Allograft Rejection—TGFB1—colon cancer	2.34e-05	0.000696	CbGpPWpGaD
Glyburide—KCNJ11—Neuronal System—HRAS—colon cancer	2.31e-05	0.000686	CbGpPWpGaD
Glyburide—ABCC3—Metabolism of lipids and lipoproteins—PPARG—colon cancer	2.28e-05	0.000677	CbGpPWpGaD
Glyburide—CPT1A—Metabolism—PPARG—colon cancer	2.17e-05	0.000644	CbGpPWpGaD
Glyburide—ABCA1—Metabolism—PPARG—colon cancer	2.17e-05	0.000644	CbGpPWpGaD
Glyburide—ABCG2—Transmembrane transport of small molecules—ABCB1—colon cancer	2.15e-05	0.000638	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—ODC1—colon cancer	2.11e-05	0.000626	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—CHST5—colon cancer	2.11e-05	0.000626	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—APC—colon cancer	2.11e-05	0.000626	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CA7—colon cancer	2.09e-05	0.000622	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—ODC1—colon cancer	2.06e-05	0.000611	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—CHST5—colon cancer	2.06e-05	0.000611	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.98e-05	0.000589	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—ABCB1—colon cancer	1.92e-05	0.000572	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—ODC1—colon cancer	1.92e-05	0.000571	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—CHST5—colon cancer	1.92e-05	0.000571	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—TYMS—colon cancer	1.89e-05	0.000562	CbGpPWpGaD
Glyburide—ABCB1—HIF-1-alpha transcription factor network—AKT1—colon cancer	1.88e-05	0.000559	CbGpPWpGaD
Glyburide—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.87e-05	0.000555	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—ABCB1—colon cancer	1.87e-05	0.000554	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—TYMS—colon cancer	1.83e-05	0.000545	CbGpPWpGaD
Glyburide—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.79e-05	0.000533	CbGpPWpGaD
Glyburide—ABCC1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.78e-05	0.00053	CbGpPWpGaD
Glyburide—CPT1A—Metabolism—PTGS2—colon cancer	1.7e-05	0.000507	CbGpPWpGaD
Glyburide—ABCA1—Metabolism—PTGS2—colon cancer	1.7e-05	0.000507	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	1.6e-05	0.000475	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.56e-05	0.000464	CbGpPWpGaD
Glyburide—ABCB11—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.55e-05	0.000462	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—ABCB1—colon cancer	1.52e-05	0.000452	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—TYMS—colon cancer	1.49e-05	0.000444	CbGpPWpGaD
Glyburide—ABCC3—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.49e-05	0.000443	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	1.48e-05	0.000441	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—ABCB1—colon cancer	1.46e-05	0.000433	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	1.45e-05	0.00043	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—TYMS—colon cancer	1.43e-05	0.000426	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	1.43e-05	0.000425	CbGpPWpGaD
Glyburide—CPT1A—Metabolism—EP300—colon cancer	1.42e-05	0.000421	CbGpPWpGaD
Glyburide—ABCA1—Metabolism—EP300—colon cancer	1.42e-05	0.000421	CbGpPWpGaD
Glyburide—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.4e-05	0.000417	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	1.4e-05	0.000416	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—PPARG—colon cancer	1.34e-05	0.000398	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	1.33e-05	0.000395	CbGpPWpGaD
Glyburide—ALB—Transmembrane transport of small molecules—ABCB1—colon cancer	1.32e-05	0.000394	CbGpPWpGaD
Glyburide—ALB—Platelet activation, signaling and aggregation—SRC—colon cancer	1.31e-05	0.00039	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—PPARG—colon cancer	1.3e-05	0.000386	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.3e-05	0.000386	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	1.29e-05	0.000384	CbGpPWpGaD
Glyburide—ALB—Platelet activation, signaling and aggregation—VEGFA—colon cancer	1.28e-05	0.00038	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—ABCB1—colon cancer	1.27e-05	0.000377	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—ODC1—colon cancer	1.27e-05	0.000377	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CHST5—colon cancer	1.27e-05	0.000377	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	1.26e-05	0.000374	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—TYMS—colon cancer	1.25e-05	0.000371	CbGpPWpGaD
Glyburide—ALB—Platelet activation, signaling and aggregation—TGFB1—colon cancer	1.17e-05	0.000349	CbGpPWpGaD
Glyburide—ABCC1—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.17e-05	0.000347	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	1.16e-05	0.000345	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	1.16e-05	0.000344	CbGpPWpGaD
Glyburide—ABCB11—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.15e-05	0.000342	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—ABCB1—colon cancer	1.14e-05	0.00034	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	1.13e-05	0.000337	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—TYMS—colon cancer	1.12e-05	0.000333	CbGpPWpGaD
Glyburide—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.1e-05	0.000328	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	1.07e-05	0.000318	CbGpPWpGaD
Glyburide—ABCC1—Disease—FGFR3—colon cancer	1.07e-05	0.000318	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—PPARG—colon cancer	1.06e-05	0.000314	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—PTGS2—colon cancer	1.05e-05	0.000313	CbGpPWpGaD
Glyburide—ABCA1—Metabolism—PIK3CA—colon cancer	1.05e-05	0.000312	CbGpPWpGaD
Glyburide—CPT1A—Metabolism—PIK3CA—colon cancer	1.05e-05	0.000312	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—PTGS2—colon cancer	1.02e-05	0.000303	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—PPARG—colon cancer	1.01e-05	0.000301	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—ABCB1—colon cancer	1.01e-05	0.000299	CbGpPWpGaD
Glyburide—ALB—Platelet activation, signaling and aggregation—PIK3CA—colon cancer	1e-05	0.000297	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—TYMS—colon cancer	9.87e-06	0.000293	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	9.84e-06	0.000292	CbGpPWpGaD
Glyburide—ABCC1—Disease—APC—colon cancer	9.83e-06	0.000292	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—PPARG—colon cancer	9.69e-06	0.000288	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	9.6e-06	0.000285	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	9.52e-06	0.000283	CbGpPWpGaD
Glyburide—ABCC1—Disease—BRAF—colon cancer	9.24e-06	0.000275	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—PPARG—colon cancer	8.83e-06	0.000263	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—EP300—colon cancer	8.76e-06	0.00026	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—colon cancer	8.7e-06	0.000259	CbGpPWpGaD
Glyburide—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	8.64e-06	0.000257	CbGpPWpGaD
Glyburide—ABCA1—Metabolism—AKT1—colon cancer	8.57e-06	0.000255	CbGpPWpGaD
Glyburide—CPT1A—Metabolism—AKT1—colon cancer	8.57e-06	0.000255	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—EP300—colon cancer	8.49e-06	0.000252	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—PTGS2—colon cancer	8.32e-06	0.000247	CbGpPWpGaD
Glyburide—ALB—Platelet activation, signaling and aggregation—AKT1—colon cancer	8.17e-06	0.000243	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	8.04e-06	0.000239	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—PTGS2—colon cancer	7.98e-06	0.000237	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—PPARG—colon cancer	7.95e-06	0.000236	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—colon cancer	7.93e-06	0.000236	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	7.62e-06	0.000227	CbGpPWpGaD
Glyburide—ABCC1—Disease—PTGS2—colon cancer	7.47e-06	0.000222	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—PPARG—colon cancer	6.99e-06	0.000208	CbGpPWpGaD
Glyburide—ALB—Hemostasis—EP300—colon cancer	6.96e-06	0.000207	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—PTGS2—colon cancer	6.95e-06	0.000207	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—EP300—colon cancer	6.92e-06	0.000206	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	6.84e-06	0.000203	CbGpPWpGaD
Glyburide—ALB—Hemostasis—SRC—colon cancer	6.77e-06	0.000201	CbGpPWpGaD
Glyburide—ABCC1—Disease—CTNNB1—colon cancer	6.68e-06	0.000199	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—EP300—colon cancer	6.64e-06	0.000197	CbGpPWpGaD
Glyburide—ALB—Hemostasis—VEGFA—colon cancer	6.6e-06	0.000196	CbGpPWpGaD
Glyburide—ABCC1—Disease—CDKN1A—colon cancer	6.53e-06	0.000194	CbGpPWpGaD
Glyburide—ALB—Hemostasis—NRAS—colon cancer	6.52e-06	0.000194	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—PIK3CA—colon cancer	6.48e-06	0.000193	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—EP300—colon cancer	6.34e-06	0.000188	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—PIK3CA—colon cancer	6.28e-06	0.000187	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—PTGS2—colon cancer	6.25e-06	0.000186	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	6.24e-06	0.000185	CbGpPWpGaD
Glyburide—ABCC1—Disease—EP300—colon cancer	6.21e-06	0.000185	CbGpPWpGaD
Glyburide—ALB—Metabolism—ABCB1—colon cancer	6.2e-06	0.000184	CbGpPWpGaD
Glyburide—ALB—Metabolism—TYMS—colon cancer	6.09e-06	0.000181	CbGpPWpGaD
Glyburide—ALB—Hemostasis—TGFB1—colon cancer	6.05e-06	0.00018	CbGpPWpGaD
Glyburide—ABCC1—Disease—SRC—colon cancer	6.04e-06	0.000179	CbGpPWpGaD
Glyburide—ABCC1—Disease—NRAS—colon cancer	5.81e-06	0.000173	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—EP300—colon cancer	5.78e-06	0.000172	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—EP300—colon cancer	5.69e-06	0.000169	CbGpPWpGaD
Glyburide—ALB—Hemostasis—KRAS—colon cancer	5.61e-06	0.000167	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—ABCB1—colon cancer	5.57e-06	0.000166	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—PTGS2—colon cancer	5.5e-06	0.000164	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—TYMS—colon cancer	5.47e-06	0.000163	CbGpPWpGaD
Glyburide—ABCC1—Disease—MYC—colon cancer	5.41e-06	0.000161	CbGpPWpGaD
Glyburide—ABCC1—Disease—TGFB1—colon cancer	5.4e-06	0.00016	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—TYMS—colon cancer	5.34e-06	0.000159	CbGpPWpGaD
Glyburide—ABCC1—Disease—EGFR—colon cancer	5.29e-06	0.000157	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—AKT1—colon cancer	5.29e-06	0.000157	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—EP300—colon cancer	5.2e-06	0.000155	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—EP300—colon cancer	5.19e-06	0.000154	CbGpPWpGaD
Glyburide—ALB—Hemostasis—PIK3CA—colon cancer	5.15e-06	0.000153	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—AKT1—colon cancer	5.13e-06	0.000153	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—PIK3CA—colon cancer	5.12e-06	0.000152	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—ABCB1—colon cancer	5.08e-06	0.000151	CbGpPWpGaD
Glyburide—ABCC1—Disease—KRAS—colon cancer	5e-06	0.000149	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—TYMS—colon cancer	4.99e-06	0.000148	CbGpPWpGaD
Glyburide—ALB—Hemostasis—TP53—colon cancer	4.98e-06	0.000148	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—PIK3CA—colon cancer	4.91e-06	0.000146	CbGpPWpGaD
Glyburide—ALB—Hemostasis—HRAS—colon cancer	4.77e-06	0.000142	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	4.69e-06	0.000139	CbGpPWpGaD
Glyburide—ABCC1—Disease—PIK3CA—colon cancer	4.59e-06	0.000137	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—EP300—colon cancer	4.58e-06	0.000136	CbGpPWpGaD
Glyburide—ALB—Metabolism—PPARG—colon cancer	4.32e-06	0.000128	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—PIK3CA—colon cancer	4.28e-06	0.000127	CbGpPWpGaD
Glyburide—ABCC1—Disease—HRAS—colon cancer	4.25e-06	0.000126	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	4.21e-06	0.000125	CbGpPWpGaD
Glyburide—ALB—Hemostasis—AKT1—colon cancer	4.21e-06	0.000125	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—AKT1—colon cancer	4.18e-06	0.000124	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—AKT1—colon cancer	4.01e-06	0.000119	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PPARG—colon cancer	3.87e-06	0.000115	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—PIK3CA—colon cancer	3.85e-06	0.000114	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	3.84e-06	0.000114	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PPARG—colon cancer	3.78e-06	0.000112	CbGpPWpGaD
Glyburide—ABCC1—Disease—AKT1—colon cancer	3.75e-06	0.000112	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PPARG—colon cancer	3.53e-06	0.000105	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—AKT1—colon cancer	3.49e-06	0.000104	CbGpPWpGaD
Glyburide—ALB—Metabolism—PTGS2—colon cancer	3.4e-06	0.000101	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—PIK3CA—colon cancer	3.39e-06	0.000101	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—ABCB1—colon cancer	3.35e-06	9.95e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—TYMS—colon cancer	3.29e-06	9.77e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—AKT1—colon cancer	3.14e-06	9.34e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PTGS2—colon cancer	3.05e-06	9.06e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PTGS2—colon cancer	2.97e-06	8.84e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—EP300—colon cancer	2.82e-06	8.39e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PTGS2—colon cancer	2.78e-06	8.26e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—AKT1—colon cancer	2.77e-06	8.22e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—EP300—colon cancer	2.53e-06	7.53e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—EP300—colon cancer	2.47e-06	7.35e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PPARG—colon cancer	2.33e-06	6.92e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—EP300—colon cancer	2.31e-06	6.87e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—PIK3CA—colon cancer	2.09e-06	6.21e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PIK3CA—colon cancer	1.88e-06	5.57e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PTGS2—colon cancer	1.83e-06	5.45e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PIK3CA—colon cancer	1.83e-06	5.44e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PIK3CA—colon cancer	1.71e-06	5.08e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—AKT1—colon cancer	1.71e-06	5.07e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—AKT1—colon cancer	1.53e-06	4.55e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—EP300—colon cancer	1.52e-06	4.53e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—AKT1—colon cancer	1.5e-06	4.44e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—AKT1—colon cancer	1.4e-06	4.15e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PIK3CA—colon cancer	1.13e-06	3.35e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—AKT1—colon cancer	9.21e-07	2.74e-05	CbGpPWpGaD
